Abbott Diabetes Care Inc.

Daniel Milfred Bernstein

Mark Kent Sloan

Gary Alan Hayter

Saeed Nekoomaram

Erwin Satrya Budiman

Martin J Fennell

Timothy Christian Dunn

Kenneth J Doniger

Michael R Love

Jean-Pierre Cole

Nathan Christopher Crouther

Marc Barry Taub

Glenn Howard Berman

Namvar Kiaie

Eric L Davis

Udo Hoss

R Curtis Jennewine

Charlene A Haley

Lei He

Christopher Allen Thomas

Theodore John Kunich

Steve Scott

Hyun Brian Cho

Songbiao Zhang

Royce Cheng

Mani Gopal

David L Li

Brittany K Bradrick

Todd Winkler

Jared Watkin

Phillip Yee

Gary Ashley Stafford

Jeffery Mario Sicurello

Howard A Wolpert

Wesley Scott Harper

Benjamin J Feldman

Louis G Pace

Hung Dinh

Christopher A Thomas

Benjamin Jay Feldman

Jeffrey Sicurello

Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user.

Medical devices and methods

Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.

Temperature-compensated analyte monitoring devices, systems, and methods thereof

Systems, devices, and methods are provided that allow detection of episodes in analyte measurement, prompting a patient to self-report possible causes for the episodes. Correlation of possible causes with detected episodes assists patient behavior modification to reduce the occurrence of episodes.

Systems, devices, and methods for episode detection and evaluation

Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.

Method, device and system for providing consistent and reliable glucose response information to physiological changes and/or activities is provided to improve glycemic control and health management.

System, device and method of dynamic glucose profile response to physiological parameters

A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.

Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance

Presented herein is a handheld analyte measurement device. The analyte measurement device includes one or more software applications to help the user manager their diabetes. Embodiments and descriptions of the various applications are provided below in conjunction with the handheld analyte measurement device.

Software applications residing on handheld analyte determining devices

Methods, apparatuses, and systems are provided for determining whether to administer a medication dose as a single dose or whether to fractionate the single dose to be administered as at least two discrete doses. Embodiments include determining a first analyte level and a first rate of change of the analyte level; determining an initial medication dose based on one or more anticipated subsequent medication doses, the first analyte level relative to an analyte level threshold, and the first rate of change of the analyte level relative to a rate of change threshold; administering the initial medication dose; determining a second analyte level and a second rate of change of the analyte level based on subsequent analyte data; and determining a subsequent medication dose based on the second analyte level relative to the analyte level threshold and the second rate of change relative to the rate of change threshold.

Optimizing medication dosage based on analyte sensor data

Display screen or portion thereof with graphical user interface for continuous glucose monitoring

A method of providing treatment for a medical condition includes storing a plurality of closed loop control algorithms in memory accessible by the control unit and receiving. A control unit receives analyte data from an analyte sensor in communication with the control unit. The control unit controls a medication delivery device in accordance with the first closed loop control algorithm based on the analyte data. The control unit causes the medication delivery device to be controlled in accordance with the second closed loop control algorithm instead of the first closed loop control algorithm, and controlling the medication delivery device in accordance with the second closed loop control algorithm. The control unit is configured to transmit one or more closed loop control operations to control the medication delivery device.

Closed loop control system interface and methods

Methods, devices and system for determining fasting glucose level information and post-prandial glucose level information for diagnosing pre-diabetic and diabetic conditions based on monitored glucose measurements are provided.

Methods, devices and system for providing diabetic condition diagnosis and therapy

Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device are provided. Various combinations of installation, functional, host integrity, coexistence, interoperability, power management, and environment checks are performed at various times to determine if the safety critical application operates properly on the device. The operation of the SCA on the UDPD may be controlled accordingly.

Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device

Growing community of inventors

El Granada, CA, United States of America

Daniel Milfred Bernstein